Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence

Cited in:

CrossRef

This article has been cited by:

1. 1
   Takeshi Tomoda, Kazuhiro Nouso, Akiko Sakai, Mamoru Ouchida, Sayo Kobayashi, Koji Miyahara, Hideki Onishi, Shinichiro Nakamura, Kazuhide Yamamoto, Kenji Shimizu, Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study, Journal of Gastroenterology and Hepatology, 2012, 27, 4

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(158K)
   • References
2. 2
   Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen, Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

   CrossRef

3. 3
   Christoph S. Klade, Elisabeth Schuller, Thomas Boehm, Alexander von Gabain, Michael P. Manns, Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination, Vaccine, 2012, 30, 19, 2943

   CrossRef

4. 4
   James M. Crawford, Alastair D. Burt, MacSween's Pathology of the Liver, 2012,

   CrossRef

5. You have free access to this content5
   Ina Bergheim, Patricia K. Eagon, Steven Dooley, Katja Breitkopf-Heinlein, Alcoholic liver disease and exacerbation by malnutrition and infections: what animal models are currently available?, Annals of the New York Academy of Sciences, 2011, 1216, 1

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(231K)
   • References
6. 6
   Jae Young Jang, Raymond T. Chung, Chronic Hepatitis C, Gut and Liver, 2011, 5, 2, 117

   CrossRef

7. 7
   Sonya A MacParland, Bahareh Vali, Mario A Ostrowski, Immunopathogenesis of HIV/hepatitis C virus coinfection, Future Virology, 2011, 6, 9, 1115

   CrossRef

8. 8
   Umberto Vespasiani-Gentilucci, Simone Carotti, Andrea Onetti-Muda, Giuseppe Perrone, Stefano Ginanni-Corradini, Maria U Latasa, Matias A Avila, Guido Carpino, Antonio Picardi, Sergio Morini, Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease, Modern Pathology, 2011, 25, 4, 576

   CrossRef

9. 9
   Kako Mishima, Naoya Sakamoto, Yuko Sekine-Osajima, Mina Nakagawa, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Kei Kiyohashi, Akiko Kitazume, Kiichiro Tsuchiya, Michio Imamura, Nobuhiko Hiraga, Kazuaki Chayama, Takaji Wakita, Mamoru Watanabe, Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants, Virology, 2010, 405, 2, 361

   CrossRef

10. 10
    Y. Ueda, Y. Takada, H. Marusawa, H. Haga, T. Sato, Y. Tanaka, H. Egawa, S. Uemoto, T. Chiba, Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation, Journal of Viral Hepatitis, 2010, 17, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(165K)
    • References
11. 11
    Tao Shen, Xiangmei Chen, Qiang Xu, Fengmin Lu, Shuang Liu, Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection, Archives of Virology, 2010, 155, 5, 627

    CrossRef

12. 12
    Shaden Muawia Hanafy, Osamma H. Shehata, Nahla M. Farahat, Expression of apoptotic markers BCL-2 and bax in chronic hepatitis C virus patients, Clinical Biochemistry, 2010, 43, 13-14, 1112

    CrossRef

13. 13
    K. Yusim, W. Fischer, H. Yoon, J. Thurmond, P. W. Fenimore, G. Lauer, B. Korber, C. Kuiken, Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity, Journal of General Virology, 2010, 91, 5, 1194

    CrossRef

14. 14
    Giuseppe Castello, Stefania Scala, Giuseppe Palmieri, Steven A. Curley, Francesco Izzo, HCV-related hepatocellular carcinoma: From chronic inflammation to cancer, Clinical Immunology, 2010, 134, 3, 237

    CrossRef

15. 15
    T. Reiberger, A. Ferlitsch, W. Sieghart, A. Kreil, F. Breitenecker, A. Rieger, B. Schmied, A. Gangl, M. Peck-Radosavljevic, HIV–HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension, Journal of Viral Hepatitis, 2010, 17, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(178K)
    • References
16. 16
    Christa Firbas, Thomas Boehm, Vera Buerger, Elisabeth Schuller, Nicolas Sabarth, Bernd Jilma, Christoph S. Klade, Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine, Vaccine, 2010, 28, 12, 2397

    CrossRef

17. 17
    Xinjian Zhang, Jun Dou, Markus W. Germann, Characterization of the cellular immune response in hepatitis C virus infection, Medicinal Research Reviews, 2009, 29, 6

    Direct Link:

    • Abstract
    • PDF(290K)
    • References
18. 18
    Mario Noti, Daniel Sidler, Thomas Brunner, Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean?, Seminars in Immunopathology, 2009, 31, 2, 237

    CrossRef

19. 19
    Alessandra Fraternale, Maria Filomena Paoletti, Anna Casabianca, Lucia Nencioni, Enrico Garaci, Anna Teresa Palamara, Mauro Magnani, GSH and analogs in antiviral therapy, Molecular Aspects of Medicine, 2009, 30, 1-2, 99

    CrossRef

20. 20
    Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa, Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies, Clinical Journal of Gastroenterology, 2009, 2, 2, 71

    CrossRef

21. 21
    J. D. Rempel, K. B. Aborsangaya, M. P. Alphonse, G. Y. Minuk, The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha, Journal of Viral Hepatitis, 2009, 16, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(157K)
    • References
22. 22
    Ron Ram, Isaac Ben-Bassat, Ofer Shpilberg, Aaron Polliack, Pia Raanani, The late adverse events of rituximab therapy – rare but there!, Leukemia & Lymphoma, 2009, 50, 7, 1083

    CrossRef

23. 23
    Qingqiong Luo, Ying Wang, Dechun Feng, Yan Xu, Lingyun Xu, Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury, European Journal of Pharmacology, 2009, 607, 1-3, 226

    CrossRef

24. 24
    Keiko Furuta, Sayaka Sato, Taeko Yamauchi, Shinichi Kakumu, Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection, Hepatology Research, 2008, 38, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(425K)
    • References
25. 25
    E. Gigi, M. Raptopoulou-Gigi, A. Kalogeridis, S. Masiou, E. Orphanou, E. Vrettou, T. H. Lalla, E. Sinakos, V. Tsapas, Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self-limited disease, Journal of Viral Hepatitis, 2008, 15, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(213K)
    • References
26. You have free access to this content26
    Muhammad Amjad, Nahed Abdel-Haq, Muhammad Faisal, Mustafa Kamal, Varsha Moudgal, Decreased interferon-α production and impaired regulatory function of plasmacytoid dendritic cells induced by the hepatitis C virus NS 5 protein, Microbiology and Immunology, 2008, 52, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(302K)
    • References
27. 27
    M. C. Villacres, O. Literat, M. DeGiacomo, W. Du, T. Frederick, A. Kovacs, Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2008, 15, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(134K)
    • References
28. 28
    Shintaro Abe, Ryoichi Narita, Toru Matsuhashi, Takeshi Oto, Akinari Tabaru, Makoto Otsuki, Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C, European Journal of Gastroenterology & Hepatology, 2008, 20, 5, 373

    CrossRef

29. 29
    Marija Zeremski, Lydia M. Petrovic, Luis Chiriboga, Queenie B. Brown, Herman T. Yee, Milan Kinkhabwala, Ira M. Jacobson, Rositsa Dimova, Marianthi Markatou, Andrew H. Talal, Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C, Hepatology, 2008, 48, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(793K)
    • References
30. 30
    Domenico Sansonno, Felicia Anna Tucci, Michele Montrone, Laura Troiani, Loredana Sansonno, Pietro Gatti, Gianfranco Lauletta, B-cell depletion in the treatment of mixed cryoglobulinemia, Digestive and Liver Disease, 2007, 39, S116

    CrossRef

31. 31
    Qiongqiong HE, Ruixue CHENG, Zhuchu CHEN, Xuxian XIAO, Zhiqiang XIAO, Cui LI, Bo LI, Pengfei ZHANG, Hui ZHENG, Deyun FENG, Cell Transformation and Proteome Alteration in QSG7701 Cells Transfected with Hepatitis C Virus Non-structural Protein 3, Acta Biochimica et Biophysica Sinica, 2007, 39, 10

    Direct Link:

    • Abstract
    • PDF(2408K)
    • References
32. 32
    Christiane Wiegard, Petra Wolint, Christian Frenzel, Uta Cheruti, Edgar Schmitt, Annette Oxenius, Ansgar W. Lohse, Johannes Herkel, Defective T Helper Response of Hepatocyte-Stimulated CD4 T Cells Impairs Antiviral CD8 Response and Viral Clearance, Gastroenterology, 2007, 133, 6, 2010

    CrossRef

33. 33
    S??bastien Dharancy, Philippe Podevin, Lynda Aoudjehane, Fr??d??ric Batteux, Arielle R. Rosenberg, Olivier Soubrane, Yvon Calmus, Filomena Conti, Elevated Interleukin-4 Expression in Severe Recurrent Hepatitis C Virus After Liver Transplantation, Transplantation, 2007, 83, 7, 906

    CrossRef

34. 34
    Ken Sato, Tetsuya Ishikawa, Akihiko Okumura, Taeko Yamauchi, Sayaka Sato, Minoru Ayada, Eiji Matsumoto, Naoki Hotta, Tomohiko Oohashi, Yoshitaka Fukuzawa, Shinichi Kakumu, Expression of Toll-like receptors in chronic hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2007, 22, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(209K)
    • References
35. 35
    Marija Zeremski, Andrew H Talal, Hepatitis C viral kinetics during treatment of hepatitis C virus/HIV coinfected patients, Current Opinion in HIV and AIDS, 2007, 2, 6, 489

    CrossRef

36. 36
    Manuela G. Neuman, Kevin Sha, Rustan Esguerra, Sam Zakhari, Robert E. Winkler, Nir Hilzenrat, Jonathan Wyse, Curtis L. Cooper, Devanshi Seth, Mark D. Gorrell, Paul S. Haber, Geoffrey W. McCaughan, Maria A. Leo, Charles S. Lieber, Mihai Voiculescu, Eugenia Buzatu, Camelia Ionescu, Jozsef Dudas, Bernhard Saile, Giuliano Ramadori, Inflammation and Repair in Viral Hepatitis C, Digestive Diseases and Sciences, 2007, 53, 6, 1468

    CrossRef

37. 37
    Masaru Moriyama, Naoya Kato, Motoyuki Otsuka, Run-Xuan Shao, Hiroyoshi Taniguchi, Takao Kawabe, Masao Omata, Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A, Hepatology International, 2007, 1, 2, 302

    CrossRef

38. 38
    Scott M. Ward, Bridget C. Fox, Philip J. Brown, Joy Worthington, Stephen B. Fox, Roger W. Chapman, Kenneth A. Fleming, Alison H. Banham, Paul Klenerman, Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection, Journal of Hepatology, 2007, 47, 3, 316

    CrossRef

39. 39
    M. Zeremski, L. M. Petrovic, A. H. Talal, The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2007, 14, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(270K)
    • References
40. 40
    G. Gutierrez-Reyes, P. Lopez-Ortal, S. Sixtos, S. Cruz, M. T. Ramirez-Iglesias, M. C. Gutierrez-Ruiz, F. Sanchez-Avila, E. Roldan, F. Vargas-Vorackova, D. Kershenobich, Effect of Pentoxifylline on Levels of Pro-inflammatory Cytokines During Chronic Hepatitis C, Scandinavian Journal of Immunology, 2006, 63, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(344K)
    • References
41. 41
    Gyongyi Szabo, Angela Dolganiuc, HCV Immunopathogenesis: Virus-Induced Strategies against Host Immunity, Clinics in Liver Disease, 2006, 10, 4, 753

    CrossRef

42. 42
    M. Irshad, Indranil Dhar, Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications, Medical Principles and Practice, 2006, 15, 6, 405

    CrossRef

43. 43
    Chen Liu, Hepatitis C Virus: Virology and Experimental Systems, Clinics in Liver Disease, 2006, 10, 4, 773

    CrossRef

44. 44
    Gadi Lalazar, Yaron Ilan, Histamine dihydrochloride: actions and efficacy in the treatment of chronic hepatitis C infection, Expert Review of Anti-infective Therapy, 2006, 4, 3, 377

    CrossRef

45. 45
    Nicasio Mancini, Silvia Carletti, Mario Perotti, Luisa Romanò, Rosellina Di Stefano Craxì, Antonio Craxì, Alessandro R. Zanetti, Massimo Clementi, Roberto Burioni, Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment, Journal of Medical Virology, 2006, 78, 10

    Direct Link:

    • Abstract
    • PDF(261K)
    • References
46. 46
    Jing Wang, Rui Sun, Haiming Wei, Zhongjun Dong, Bin Gao, Zhigang Tian, Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism, Journal of Hepatology, 2006, 44, 3, 446

    CrossRef

47. 47
    Laura Milazzo, Mara Biasin, Nadia Gatti, Luca Piacentini, Fosca Niero, Barbara Zanone Poma, Massimo Galli, Mauro Moroni, Mario Clerici, Agostino Riva, Thalidomide in the Treatment of Chronic Hepatitis C Unresponsive to Alfa-Interferon and Ribavirin, The American Journal of Gastroenterology, 2006, 101, 2, 399

    CrossRef

48. 48
    D. Sansonno, G. Lauletta, M. Montrone, F. A. Tucci, L. Nisi, F. Dammacco, Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia, Clinical & Experimental Immunology, 2006, 143, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(225K)
    • References
49. 49
    John S. Bradley, Infectious Diseases of the Fetus and Newborn Infant, 2006,

    CrossRef

50. 50
    Jin-Ying Lu, Lee-Ming Chuang, Wei-Shiung Yang, Tong-Yuan Tai, Ming-Yang Lai, Pei-Jer Chen, Jia-Horng Kao, Cha-Ze Lee, Hsuan-Shu Lee, Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-α therapy, Liver International, 2005, 25, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(136K)
    • References
51. 51
    Susan Morgello, Lydia Estanislao, Elizabeth Ryan, Pieter Gerits, David Simpson, Susama Verma, Alessandro DiRocco, Victoria Sharp, Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals, AIDS, 2005, 19, Suppl 3, S116

    CrossRef

52. 52
    A. Apolinario, P. L. Majano, R. Lorente, O. Núñez, G. Clemente, C. García-Monzón, Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins, Journal of Viral Hepatitis, 2005, 12, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1107K)
    • References
53. 53
    Francesca Fioredda, Anna Rita Gigliotti, Riccardo Haupt, Maria Grazia Calevo, Cinzia Lo Giudice, Laura Bocciardo, Raffaella Giacchino, HCV Infection in Very-Long-Term Survivors After Cancer Chemotherapy and Bone Marrow Transplantation, Journal of Pediatric Hematology/Oncology, 2005, 27, 9, 481

    CrossRef

54. 54
    Domenico Sansonno, Felicia Anna Tucci, Valli De Re, Gianfranco Lauletta, Michele Montrone, Massimo Libra, Franco Dammacco, HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation , Hepatology, 2005, 42, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(605K)
    • References
55. 55
    Christel Gremion, Andreas Cerny, Hepatitis C virus and the immune system: a concise review, Reviews in Medical Virology, 2005, 15, 4

    Direct Link:

    • Abstract
    • PDF(436K)
    • References
56. 56
    Atsushi Yamaguchi, Susumu Tazuma, Tomoji Nishioka, Waka Ohishi, Hideyuki Hyogo, Shuichi Nomura, Kazuaki Chayama, Hepatitis C Virus Core Protein Modulates Fatty Acid Metabolism and Thereby Causes Lipid Accumulation in the Liver, Digestive Diseases and Sciences, 2005, 50, 7, 1361

    CrossRef

57. 57
    Patrice Cacoub, David Saadoun, Nicolas Limal, Jean Marc Léger, Thierry Maisonobe, Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications, AIDS, 2005, 19, Suppl 3, S128

    CrossRef

58. 58
    George M. Lauer, Hepatitis C virus–specific CD8⁺ T cells restricted by donor HLA alleles following liver transplantation, Liver Transplantation, 2005, 11, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(61K)
    • References
59. 59
    Rainer P. Woitas, Bodo Stoschus, Birgit Terjung, Martin Vogel, Bernd Kupfer, Hans H. Brackmann, Jürgen K. Rockstroh, Tilman Sauerbruch, Ulrich Spengler, Hepatitis C-associated autoimmunity in patients coinfected with HIV, Liver International, 2005, 25, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(131K)
    • References
60. 60
    Abdelfattah M. Attallah, Gellan G. Ibrahim, Immunodetection of a Hepatitis C Virus (HCV) Antigen and Th1/Th2 Cytokines in Cerebrospinal Fluid of Meningitis Patients, Journal of Immunoassay and Immunochemistry, 2005, 25, 4, 313

    CrossRef

61. 61
    Sébastien Dharancy, Mathilde Malapel, Gabriel Perlemuter, Tania Roskams, Yang Cheng, Laurent Dubuquoy, Philippe Podevin, Filoména Conti, Valérie Canva, David Philippe, Luc Gambiez, Philippe Mathurin, Jean-Claude Paris, Kristina Schoonjans, Yvon Calmus, Stanislas Pol, Johan Auwerx, Pierre Desreumaux, Impaired expression of the peroxisome proliferator–activated receptor alpha during hepatitis C virus infection, Gastroenterology, 2005, 128, 2, 334

    CrossRef

62. 62
    Srikanta Dash, Ramesh Prabhu, Sidhartha Hazari, Frank Bastian, Robert Garry, Weiping Zou, Salima Haque, Virendra Joshi, Fredric G. Regenstein, Swan N. Thung, Interferons α, β, γ each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation, Liver International, 2005, 25, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(4097K)
    • References
63. 63
    I. M. El-Kady, M. Lotfy, G. Badra, S. El-Masry, I. Waked, Interleukin (IL)-4, IL-10, IL-18 and IFN-γ Cytokines Pattern in Patients with Combined Hepatitis C Virus and Schistosoma mansoni Infections, Scandinavian Journal of Immunology, 2005, 61, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(119K)
    • References
64. 64
    Naoya Kato, Guijin Ji, Yue Wang, Masanori Baba, Yujin Hoshida, Motoyuki Otsuka, Hiroyoshi Taniguchi, Masaru Moriyama, Narayan Dharel, Tadashi Goto, Run-Xuan Shao, Tadashi Matsuura, Keisuke Ishii, Shuichiro Shiina, Takao Kawabe, Masaaki Muramatsu, Masao Omata, Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C, Hepatology, 2005, 42, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(138K)
    • References
65. 65
    Karina Yusim, Russell Richardson, Ning Tao, Anita Dalwani, Ashish Agrawal, James Szinger, Robert Funkhouser, Bette Korber, Carla Kuiken, Los Alamos Hepatitis C Immunology Database, Applied Bioinformatics, 2005, 4, 4, 217

    CrossRef

66. 66
    Martine Neau-Cransac, Juliette Foucher, Victor De Ledinghen, Pierre-Henri Bernard, Elisabeth Legrand, Marie-Edith Lafon, Modifications of T-Lymphocyte Subsets before and during Interferon and Ribavirin Treatment for Chronic Hepatitis C Infection, Viral Immunology, 2005, 18, 1, 197

    CrossRef

67. 67
    Matthew M Yeh, Zelma J Buskell, Leonard B Seeff, Doris Strader, Elizabeth C Wright, Zachary D Goodman, More Severe Parenchymal Injury in Chronic Hepatitis C Acquired by Recent Injection Drug Use, Journal of Clinical Gastroenterology, 2005, 39, 8, 722

    CrossRef

68. 68
    Nasser Semmo, Cheryl L. Day, Scott M. Ward, Michaela Lucas, Gillian Harcourt, Andrew Loughry, Paul Klenerman, Preferential loss of IL-2–secreting CD4+ T helper cells in chronic HCV infection, Hepatology, 2005, 41, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1405K)
    • References
69. 69
    Shinji Takai, Hisashi Tsurumi, Kazuki Ando, Senji Kasahara, Michio Sawada, Toshiki Yamada, Takeshi Hara, Kenji Fukuno, Takeshi Takahashi, Masami Oyama, Hiroo Onishi, Eiichi Tomita, Tsuyoshi Takami, Michio Imawari, Hisataka Moriwaki, Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy, European Journal of Haematology, 2005, 74, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(144K)
    • References
70. 70
    Kwok H. Tang, Eva Herrmann, Helen Cooksley, Nick Tatman, Shilpa Chokshi, Roger Williams, Stefan Zeuzem, Nikolai V. Naoumov, Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy, Journal of Hepatology, 2005, 43, 5, 776

    CrossRef

71. 71
    Laura Sosa, Debbie Vidlak, Jennifer M. Strachota, Jackie Pavlik, Thomas R. Jerrells, Rescue of in vivo FAS-induced apoptosis of hepatocytes by corticosteroids either associated with alcohol consumption by mice or provided exogenously, International Immunopharmacology, 2005, 5, 2, 301

    CrossRef

72. 72
    A. Farid, M. Al-Sherbiny, A. Osman, N. Mohamed, A. Saad, M. T. Shata, D.-H. Lee, A. M. Prince, G. T. Strickland, Schistosoma infection inhibits cellular immune responses to core HCV peptides, Parasite Immunology, 2005, 27, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(172K)
    • References
73. 73
    Alla Melhem, Mirela Stern, Oren Shibolet, Eran Israeli, Zvi Ackerman, Orit Pappo, Nilla Hemed, Mina Rowe, Hana Ohana, George Zabrecky, Robert Cohen, Yaron Ilan, Treatment of Chronic Hepatitis C Virus Infection via Antioxidants, Journal of Clinical Gastroenterology, 2005, 39, 8, 737

    CrossRef

74. 74
    Eric J. Lawitz, Matthew J. Hepburn, Thomas J. Casey, A Pilot Study of Interleukin-11 in Subjects with Chronic Hepatitis C and Advanced Liver Disease Nonresponsive to Antiviral Therapy, The American Journal of Gastroenterology, 2004, 99, 12, 2359

    CrossRef

75. 75
    Laurent Vallat, Yves Benhamou, Maya Gutierrez, Pascale Ghillani, Christel Hercher, Vincent Thibault, Frédéric Charlotte, Jean-Charles Piette, Thierry Poynard, Hélène Merle-Béral, Frédéric Davi, Patrice Cacoub, Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection, Arthritis & Rheumatism, 2004, 50, 11

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(111K)
    • References
76. 76
    X. Jiao, R. Y.-H. Wang, Z. Feng, G. Hu, H. J. Alter, J. W.-K. Shih, DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response, Journal of Viral Hepatitis, 2004, 11, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(162K)
    • References
77. 77
    Anna Linda Zignego, Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues, Journal of Hepatology, 2004, 41, 6, 1045

    CrossRef

78. 78
    Krister Melén, Riku Fagerlund, Maria Nyqvist, Päivi Keskinen, Ilkka Julkunen, Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs, Journal of Medical Virology, 2004, 73, 4

    Direct Link:

    • Abstract
    • PDF(557K)
    • References
79. 79
    Satoshi Mochida, Michie Hashimoto, Atsushi Matsui, Masashi Naito, Mie Inao, Sumiko Nagoshi, Makoto Nagano, Tohru Egashira, Shunji Mishiro, Kenji Fujiwara, Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients, Biochemical and Biophysical Research Communications, 2004, 313, 4, 1079

    CrossRef

80. 80
    Angela Dolganiuc, Shilpa Oak, Karen Kodys, Douglas T. Golenbock, Robert W. Finberg, Evelyn Kurt-Jones, Gyongyi Szabo, Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation, Gastroenterology, 2004, 127, 5, 1513

    CrossRef

81. 81
    M. Anzola, Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis, Journal of Viral Hepatitis, 2004, 11, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(444K)
    • References
82. 82
    Yasunobu Fukuda, Hiroshi Yotsuyanagi, Seido Ooka, Taichi Sekine, Junki Koike, Toshifumi Takano, Michihiro Suzuki, Fumio Itoh, Kusuki Nishioka, Tomohiro Kato, Identification of a new autoantibody in patients with chronic hepatitis, Human Immunology, 2004, 65, 12, 1530

    CrossRef

83. 83
    Dimple Raina, George Y. Wu, Immunopathogenesis of hepatitis C virus infection, Current Hepatitis Reports, 2004, 3, 4, 136

    CrossRef

84. 84
    Olivier Disson, Delphine Haouzi, Solange Desagher, Kim Loesch, Michael Hahne, Eric J. Kremer, Chantal Jacquet, Stanley M. Lemon, Urszula Hibner, Hervé Lerat, Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein, Gastroenterology, 2004, 126, 3, 859

    CrossRef

85. 85
    A. Apolinario, M. Diago, O. Lo Iacono, R. Lorente, C. Pérez, P. L. Majano, G. Clemente, C. García-Monzón, Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy, Alimentary Pharmacology & Therapeutics, 2004, 19, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(286K)
    • References
86. 86
    Svetlana Radaeva, Rui Sun, Hong-na Pan, Feng Hong, Bin Gao, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, 2004, 39, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(1285K)
    • References
87. 87
    Mariano Malaguarnera, Giovanni Pistone, Sergio Neri, Marcello Romano, Alfio Brogna, Salvatore Musumeci, Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment, BioDrugs, 2004, 18, 6, 407

    CrossRef

88. 88
    Johannes Wiegand, Elmar Jäckel, Markus Cornberg, Holger Hinrichsen, Manfred Dietrich, Julian Kroeger, Wolfgang P. Fritsch, Anne Kubitschke, Nuray Aslan, Hans L. Tillmann, Michael Peter Manns, Heiner Wedemeyer, Long-term follow-up after successful interferon therapy of acute hepatitis C, Hepatology, 2004, 40, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(221K)
    • References
89. 89
    Teresa Casanovas-Taltavull, M. Guadalupe Ercilla, Cecilia P. Gonzalez, Elias Gil, Odette Viñas, Concha Cañas, Aurora Casanova, Juan Figueras, Teresa Serrano, Luis A. Casais, Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance, Liver Transplantation, 2004, 10, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(269K)
    • References
90. 90
    Geoffrey W McCaughan, Amany Zekry, Mechanisms of HCV reinfection and allograft damage after liver transplantation, Journal of Hepatology, 2004, 40, 3, 368

    CrossRef

91. 91
    Sanaa M. Kamal, Alaa Ismail, Camilla S. Graham, Qi He, Jens W. Rasenack, Thomas Peters, Ahmed A. Tawil, Jutta J. Fehr, Khalifa El Sayed Khalifa, Mahmoud M. Madwar, Margaret James Koziel, Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics, Hepatology, 2004, 39, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(658K)
    • References
92. 92
    Volker Brass, Hubert E Blum, Darius Moradpour, Recent developments in target identification against hepatitis C virus, Expert Opinion on Therapeutic Targets, 2004, 8, 4, 295

    CrossRef

93. 93
    David G. Bowen, Monica Zen, Lauren Holz, Thomas Davis, Geoffrey W. McCaughan, Patrick Bertolino, The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity, Journal of Clinical Investigation, 2004, 114, 5, 701

    CrossRef

94. 94
    A.R Ciccaglione, C Marcantonio, E Tritarelli, M Equestre, F Magurano, A Costantino, L Nicoletti, M Rapicetta, The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death, Virus Research, 2004, 104, 1, 1

    CrossRef

95. 95
    Satoshi Mochida, Takayuki Yoshimoto, Sumie Mimura, Mie Inao, Atsushi Matsui, Akihiko Ohno, HeaSaeng Koh, Eiko Saitoh, Sumiko Nagoshi, Kenji Fujiwara, Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis, Biochemical and Biophysical Research Communications, 2004, 317, 1, 114

    CrossRef

96. 96
    Yasunari Nakamoto, Shuichi Kaneko, Hisao Takizawa, Yoshikazu Kikumoto, Masaaki Takano, Yoshiko Himeda, Kenichi Kobayashi, Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A^*2402 peptide tetramers, Journal of Medical Virology, 2003, 70, 1

    Direct Link:

    • Abstract
    • PDF(411K)
    • References
97. 97
    Carl Albrecht Schirren, Reinhart Zachoval, Joern Tilman Gerlach, Axel Ulsenheimer, Norbert Hubert Gruener, Helmut Michael Diepolder, Gustavo Baretton, Winfried Schraut, Horst-Guenter Rau, Hans Nitschko, Gerd Rudolf Pape, Maria-Christina Jung, Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination, Journal of Hepatology, 2003, 39, 3, 397

    CrossRef

98. 98
    Umesh Gaud, Barbara Langer, Theoni Petropoulou, Howard C. Thomas, Peter Karayiannis, Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects, Journal of Medical Virology, 2003, 69, 3

    Direct Link:

    • Abstract
    • PDF(94K)
    • References
99. 99
    F. Zoulim, M. Chevallier, M. Maynard, C. Trepo, Clinical consequences of hepatitis C virus infection, Reviews in Medical Virology, 2003, 13, 1

    Direct Link:

    • Abstract
    • PDF(544K)
    • References
100. 100
     David Durantel, Vanessa Escuret, Fabien Zoulim, Current and emerging therapeutic approaches to hepatitis C infection, Expert Review of Anti-infective Therapy, 2003, 1, 3, 441

     CrossRef

101. 101
     Thomas Hügle, Andreas Cerny, Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C, Reviews in Medical Virology, 2003, 13, 6

     Direct Link:

     • Abstract
     • PDF(159K)
     • References
102. 102
     Dimitrios-Petrou Bogdanos, Ian G McFarlane, Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity, Journal of Hepatology, 2003, 39, 5, 860

     CrossRef

103. 103
     Georgios N Dalekos, Petra Obermayer-Straub, Moritz Bartels, Takashi Maeda, Anne Kayser, Sabine Braun, Stephanie Loges, Eleonore Schmidt, M.Eric Gershwin, Michael P Manns, Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection, Journal of Hepatology, 2003, 39, 5, 800

     CrossRef

104. 104
     Bach-Nga Pham, Michèle Martinot-Peignoux, Dominique Valla, Sylvie Dubois, Claude Degott, Jean-FranÇois Mosnier, Differential expression of perforin and granzyme B in the liver of patients with chronic hepatitis C, Human Pathology, 2003, 34, 8, 770

     CrossRef

105. 105
     Alex Blindenbacher, Francois H.T. Duong, Lukas Hunziker, Simone T.D. Stutvoet, Xueya Wang, Luigi Terracciano, Darius Moradpour, Hubert E. Blum, Tonino Alonzi, Marco Tripodi, Nicola La Monica, Markus H. Heim, Expression of hepatitis c virus proteins inhibits interferon α signaling in the liver of transgenic mice, Gastroenterology, 2003, 124, 5, 1465

     CrossRef

106. 106
     Antonello Pietrangelo, Hemochromatosis gene modifies course of hepatitis C viral infection, Gastroenterology, 2003, 124, 5, 1509

     CrossRef

107. 107
     Anna Rita Gigliotti, Francesca Fioredda, Raffaella Giacchino, Hepatitis B and C Infection in Children Undergoing Chemotherapy or Bone Marrow Transplantation, Journal of Pediatric Hematology/Oncology, 2003, 25, 3, 184

     CrossRef

108. 108
     Alfredo Alberti, Luisa Benvegnù, Management of hepatitis C, Journal of Hepatology, 2003, 38, 104

     CrossRef

109. 109
     Patricia E. Molina, Jan B. Hoek, Steve Nelson, David M. Guidot, Charles H. Lang, Jack R. Wands, James M. Crawford, Mechanisms of Alcohol-Induced Tissue Injury, Alcoholism: Clinical and Experimental Research, 2003, 27, 3

     Direct Link:

     • Abstract
     • PDF(117K)
     • References
110. 110
     Jane H Wang, Thomas J Layden, David D Eckels, Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response, Human Immunology, 2003, 64, 7, 662

     CrossRef

111. 111
     Kenneth D. Phillips, Robyn Brewer, Pathophysiology of Hepatitis C and HIV Coinfection, Journal of the Association of Nurses in AIDS care, 2003, 14, 5, 27S

     CrossRef

112. 112
     Jens Schümann, Jennifer Prockl, Alexandra K Kiemer, Angelika M Vollmar, Renate Bang, Gisa Tiegs, Silibinin protects mice from T cell-dependent liver injury☆, Journal of Hepatology, 2003, 39, 3, 333

     CrossRef

113. 113
     T. Andrieu, V. Thibault, I. Malet, J. Laporte, B. Bauvois, H. Agut, A. Cahour, Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections, Journal of Clinical Virology, 2003, 27, 1, 59

     CrossRef

114. 114
     Young S Hahn, Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?, Current Opinion in Immunology, 2003, 15, 4, 443

     CrossRef

115. 115
     Nicole Pavio, Michael M. C. Lai, The hepatitis C virus persistence: how to evade the immune system?, Journal of Biosciences, 2003, 28, 3, 287

     CrossRef

116. 116
     Anthony J Freeman, Yong Pan, Charles E Harvey, Jeffrey J Post, Matthew G Law, Peter A White, William D Rawlinson, Andrew R Lloyd, George Marinos, Rosemary A Ffrench, The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection, Journal of Hepatology, 2003, 38, 3, 349

     CrossRef

117. 117
     Koichi Watashi, Kunitada Shimotohno, The roles of hepatitis C virus proteins in modulation of cellular functions: A novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors, Cancer Science, 2003, 94, 11

     Direct Link:

     • Abstract
     • PDF(2263K)
     • References
118. 118
     P Ferenci, Weight-based dosing of pegylated interferon-alpha in chronic hepatitis C, Digestive and Liver Disease, 2003, 35, 9, 601

     CrossRef

119. 119
     Robert Thimme, Hans-Christian Spangenberg, Hubert E. Blum, Bridge over troubled water: Protection against hepatitis C virus persistence?, Hepatology, 2002, 36, 6

     Direct Link:

     • Abstract
     • PDF(368K)
     • References
120. 120
     Jonathan Moorman, Challenges in the HIV patient coinfected with hepatitis C, Current Hepatitis Reports, 2002, 1, 1, 9

     CrossRef

121. 121
     Jay H. Hoofnagle, Course and outcome of hepatitis C, Hepatology, 2002, 36, S1

     Direct Link:

     • Abstract
     • PDF(1085K)
     • References
122. 122
     Tina Deignan, Michael P Curry, Derek G Doherty, Lucy Golden-Mason, Yuri Volkov, Suzanne Norris, Niamh Nolan, Oscar Traynor, Gerry McEntee, John E Hegarty, Cliona O'Farrelly, Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infection, Journal of Hepatology, 2002, 37, 1, 101

     CrossRef

123. 123
     Alhusain J Alzahrani, Pamela J Vallely, Raymond F.T McMahon, Development of a novel nested in situ PCR–ISH method for detection of hepatitis C virus RNA in liver tissue, Journal of Virological Methods, 2002, 99, 1-2, 53

     CrossRef

124. 124
     Miguel A Rico, Juan A Quiroga, Dolores Subirá, Esteban Garcia, Susana Castañón, Matti Sällberg, Geert Leroux-Roels, Ola Weiland, Margarita Pardo, Vicente Carreño, Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels, Journal of Hepatology, 2002, 36, 3, 408

     CrossRef

125. 125
     Darius Moradpour, Volker Brass, Rainer Gosert, Benno Wölk, Hubert E. Blum, Hepatitis C: molecular virology and antiviral targets, Trends in Molecular Medicine, 2002, 8, 10, 476

     CrossRef

126. 126
     Ian R Mackay, Hepatoimmunology: A perspective, Immunology and Cell Biology, 2002, 80, 1, 36

     CrossRef

127. 127
     Rafael Quadri, Emiliano Giostra, Tania Roskams, Jean-Michel Pawlotsky, Gilles Mentha, Laura Rubbia-Brandt, Luc Perrin, Antoine Hadengue, Francesco Negro, IMMUNOLOGICAL AND VIROLOGICAL EFFECTS OF RIBAVIRIN IN HEPATITIS C AFTER LIVER TRANSPLANTATION1, Transplantation, 2002, 73, 3, 373

     CrossRef

128. 128
     Ding-You Li, Kathleen B. Schwarz, Immunopathogenesis of Chronic Hepatitis C Virus Infection, Journal of Pediatric Gastroenterology and Nutrition, 2002, 35, 3, 260

     CrossRef

129. 129
     S. Einav, M.J. Koziel, S., M.J. Einav Koziel, Immunopathogenesis of hepatitis C virus in the immunosuppressed host, Transplant Infectious Disease, 2002, 4, 2

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(129K)
     • References
130. 130
     Naohisa Ibuki, Kazuhide Yamamoto, Kazuhisa Yabushita, Nobuaki Okano, Ryoichi Okamoto, Noriaki Shimada, Tomomi Hakoda, Motowo Mizuno, Toshihiro Higashi, Takao Tsuji, In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis, Liver, 2002, 22, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(399K)
     • References
131. 131
     Thomas R. Jerrells, Kristen Mitchell, Jacqueline Pavlik, Jennifer Jerrells, Debbie Hoerman, Influence of Ethanol Consumption on Experimental Viral Hepatitis, Alcoholism: Clinical and Experimental Research, 2002, 26, 11

     Direct Link:

     • Abstract
     • PDF(1993K)
     • References
132. 132
     Thomas R. Jerrells, Kristen Mitchell, Jacqueline Pavlik, Jennifer Jerrells, Debbie Hoerman, Influence of Ethanol Consumption on Experimental Viral Hepatitis, Alcoholism: Clinical & Experimental Research, 2002, 26, 11, 1734

     CrossRef

133. 133
     S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R. M. Brunetto, F. Bonino, S. Abrignani, N. M. Valiante, Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein, Journal of Experimental Medicine, 2002, 195, 1, 35

     CrossRef

134. 134
     Nicholas A. Shackel, Peter H. McGuinness, Catherine A. Abbott, Mark D. Gorrell, Geoffrey W. McCaughan, Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis, The American Journal of Pathology, 2002, 160, 2, 641

     CrossRef

135. 135
     Laura Rubbia-Brandt, Sophia Taylor, Patrizia Gindre, Rafael Quadri, Karim Abid, Laurent Spahr, Francesco Negro, Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus, The Journal of Pathology, 2002, 197, 5

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(223K)
     • References
136. 136
     Geoffrey M. Thiele, Gyongyi Szabo, Elizabeth J. Kovacs, Abraham P. Bautista, Laura Sosa, Thomas R. Jerrells, Modulation of Immunity and Viral-Host Interactions by Alcohol, Alcoholism: Clinical & Experimental Research, 2002, 26, 12, 1897

     CrossRef

137. 137
     Geoffrey M. Thiele, Gyongyi Szabo, Elizabeth J. Kovacs, Abraham P. Bautista, Laura Sosa, Thomas R. Jerrells, Modulation of Immunity and Viral-Host Interactions by Alcohol, Alcoholism: Clinical and Experimental Research, 2002, 26, 12

     Direct Link:

     • Abstract
     • PDF(108K)
     • References
138. 138
     T. Lancaster, E. Sanders, J. M. L. Christie, C. Brooks, S. Green, W. M. C. Rosenberg, Quantitative and functional differences in CD8⁺ lymphocyte responses in resolved acute and chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2002, 9, 1

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(506K)
     • References
139. 139
     Thomas R. Jerrells, Role of activated CD8+ T cells in the initiation and continuation of hepatic damage, Alcohol, 2002, 27, 1, 47

     CrossRef

140. 140
     Patrick Bertolino, Geoffrey W McCaughan, David G Bowen, Role of primary intrahepatic T-cell activation in the 'liver tolerance effect', Immunology and Cell Biology, 2002, 80, 1, 84

     CrossRef

141. 141
     M. PERNOLLET, E. JOUVIN-MARCHE, V. LEROY, I. VIGAN, J.-P. ZARSKI, P. N. MARCHE, Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions, Clinical & Experimental Immunology, 2002, 130, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(164K)
     • References
142. 142
     Andrew H. Talal, P. Wilfredo Canchis, Ira M. Jacobson, The HCV and HIV coinfected patient: What have we learned about pathophysiology?, Current Gastroenterology Reports, 2002, 4, 1, 15

     CrossRef

143. 143
     K. SUZUKI, M. YANAGI, A. MORI-AOKI, E. MORIYAMA, K. J. ISHII, L. D. KOHN, Transfection of single-stranded hepatitis A virus RNA activates MHC class I pathway, Clinical & Experimental Immunology, 2002, 127, 2

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(615K)
     • References
144. 144
     Andreas Cerny, Viral crosstalk: Who gets to say what first?, Hepatology, 2002, 35, 6

     Direct Link:

     • Abstract
     • PDF(54K)
     • References
145. 145
     D.X. Liu, A new hypothesis of pathogenetic mechanism of viral hepatitis B and C, Medical Hypotheses, 2001, 56, 3, 405

     CrossRef

146. 146
     Shane Patella, David J Phillips, David M de Kretser, Lee W Evans, Nigel P Groome, William Sievert, Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis, Journal of Hepatology, 2001, 34, 4, 576

     CrossRef

147. 147
     George K Koukoulis, Chronic hepatitis C: Grading, staging, and searching for reliable predictors of outcome, Human Pathology, 2001, 32, 9, 899

     CrossRef

148. 148
     Mathis Heydtmann, Philip Shields, Geoffrey McCaughan, David Adams, Cytokines and chemokines in the immune response to hepatitis C infection, Current Opinion in Infectious Diseases, 2001, 14, 3, 279

     CrossRef

149. 149
     Elias Toubi, Aharon Kessel, Lee Goldstein, Gleb Slobodin, Edmond Sabo, Zehava Shmuel, Eli Zuckerman, Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity, Journal of Hepatology, 2001, 35, 6, 774

     CrossRef

150. 150
     F. Querenghi, Qiang Yu, G. Billaud, G. Maertens, C. Trépo, F. Zoulim, Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy, Journal of Viral Hepatitis, 2001, 8, 2

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(527K)
     • References
151. 151
     Shinn-Jang Hwang, Shou-Dong Lee, Rei-Hwa Lu, Chen-Wei Chu, Jaw-Ching Wu, Shiau-Ting Lai, Full-Young Chang, Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C, Journal of Medical Virology, 2001, 65, 3

     Direct Link:

     • Abstract
     • PDF(87K)
     • References
152. 152
     Zhi Qiang Yao, Suma Ray, Audrey Eisen-Vandervelde, Stephen Waggoner, Young S. Hahn, Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway, Viral Immunology, 2001, 14, 4, 277

     CrossRef

153. 153
     Anthony J Freeman, George Marinos, Rosemary A Ffrench, Andrew R Lloyd, Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001, 79, 6, 515

     CrossRef

154. 154
     M.P Busch, Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients, Transfusion Clinique et Biologique, 2001, 8, 3, 200

     CrossRef

155. 155
     G. Piazzolla, C. Tortorella, G. Fiore, M. Fanelli, A. Pisconti, S. Antonaci, Interleukin-12 p40/p70 Ratio andIn VivoResponsiveness to IFN-αTreatment in Chronic Hepatitis C, Journal of Interferon & Cytokine Research, 2001, 21, 7, 453

     CrossRef

156. 156
     Jonathan P. Moorman, Issues in HIV/hepatitis C co-infection, Current Infectious Disease Reports, 2001, 3, 2, 131

     CrossRef

157. 157
     Yasunari Nakamoto, Shuichi Kaneko, Kenichi Kobayashi, Monocyte-dependent cell death of T lymphocyte subsets in chronic hepatitis C, Immunology Letters, 2001, 78, 3, 169

     CrossRef

158. 158
     Isabelle P. Hunziker, Rinaldo Zurbriggen, Reinhard Glueck, Olivier B. Engler, Jürg Reichen, Wen Juan Dai, Werner J. Pichler, Andreas Cerny, Perspectives: towards a peptide-based vaccine against hepatitis C virus, Molecular Immunology, 2001, 38, 6, 475

     CrossRef

159. 159
     Fabien Zoulim, Quantification and genotyping in management of chronic hepatitis B and C, Virus Research, 2001, 82, 1-2, 45

     CrossRef

160. 160
     Gerd Hempel, Peter R. Galle, Hanns F. Löhr, Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C, Journal of Medical Virology, 2001, 64, 3

     Direct Link:

     • Abstract
     • PDF(217K)
     • References
161. 161
     Luigi Aurisicchio, Alessandra Ceccacci, Nicola La Monica, Fabio Palombo, Cinzia Traboni, Tamarin alpha-interferon is active in mouse liver upon intramuscular gene delivery, The Journal of Gene Medicine, 2001, 3, 4

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(199K)
     • References
162. 162
     George V. Papatheodoridis, Susan Davies, Amar P. Dhillon, Rosangela Teixeira, John Goulis, Brian Davidson, Keith Rolles, Geoffrey Dusheiko, Andrew K. Burroughs, THE ROLE OF DIFFERENT IMMUNOSUPPRESSION IN THE LONG-TERM HISTOLOGICAL OUTCOME OF HCV REINFECTION AFTER LIVER TRANSPLANTATION FOR HCV CIRRHOSIS, Transplantation, 2001, 72, 3, 412

     CrossRef

163. 163
     Jay H. Hoofnagle, Therapy for Acute Hepatitis C, New England Journal of Medicine, 2001, 345, 20, 1495

     CrossRef

164. 164
     Ke-Qin Hu, John M. Vierling, Allan G. Redeker, Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 1, 1

     CrossRef

165. 165
     Ke-Qin Hu, John M. Vierling, Allan G. Redeker, Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 1

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(227K)
     • References
166. 166
     Caterina Prezzi, Marco Antonio Casciaro, Vittorio Francavilla, Enrico Schiaffella, Luigi Finocchi, Lucia Valeria Chircu, Guglielmo Bruno, Alessandro Sette, Sergio Abrignani, Vincenzo Barnaba, Virus-specific CD8⁺ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection, European Journal of Immunology, 2001, 31, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(239K)
     • References
167. 167
     S. Locarnini, A virological perspective on the need for vaccination, Journal of Viral Hepatitis, 2000, 7,

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(49K)
     • References
168. 168
     Claude Souvignet, Jean-Pierre Zarski, Combination treatment for chronic hepatitis C: what is the role of ribavirin?, Fundamental & Clinical Pharmacology, 2000, 14, 4

     Direct Link:

     • Abstract
     • PDF(470K)
     • References
169. 169
     Michael P. Manns, Hepatitis C and autoimmune hepatitis, Hepatology, 2000, 31, 3

     Direct Link:

     • Abstract
     • PDF(30K)
     • References
170. 170
     IAN M. ZITRON, MARIUS LAURINAITIS, LIHUA QU, ANN L. SILVERMAN, STUART C. GORDON, Immunological Responses in Patients Who Have Spontaneously Eradicated Hepatitis C Virus Infection, Viral Immunology, 2000, 13, 4, 521

     CrossRef

171. 171
     M.H. Heim, Intracellular signalling and antiviral effects of interferons, Digestive and Liver Disease, 2000, 32, 3, 257

     CrossRef

172. 172
     Christian Brander, Bruce D Walker, Modulation of host immune responses by clinically relevant human DNA and RNA viruses, Current Opinion in Microbiology, 2000, 3, 4, 379

     CrossRef

173. 173
     Stephen Locarnini, Molecular pathogenesis of viral hepatitis, Journal of Gastroenterology and Hepatology, 2000, 15,

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(46K)
     • References
174. 174
     Antonio Bertoletti, Mala K Maini, Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?, Current Opinion in Immunology, 2000, 12, 4, 403

     CrossRef

175. 175
     Antonio Bertoletti, Mala K Maini, Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?, Current Opinion in Microbiology, 2000, 3, 4, 387

     CrossRef

176. 176
     J.M. Pawlotsky, Virus de l'hépatite C: interactions virus-hôte et diagnostic biologique, Médecine et Maladies Infectieuses, 2000, 30, S14

     CrossRef

177. 177
     D.-P. Bogdanos, G. Mieli-Vergani, D. Vergani, Virus, liver and autoimmunity, Digestive and Liver Disease, 2000, 32, 5, 440

     CrossRef